Please use this identifier to cite or link to this item: http://repositorio.unifesp.br/handle/11600/32550
Title: Bradykinin inducible receptor is essential to lipopolysaccharide-induced acute lung injury in mice
Authors: Campanholle, Gabriela
Landgraf, Richardt G. [UNIFESP]
Borducchi, Erica
Semedo, Patricia [UNIFESP]
Wang, Pamela H. M. [UNIFESP]
Amano, Mariane T.
Russo, Momtchilo
Pacheco-Silva, Alvaro [UNIFESP]
Jancar, Sonia
Camara, Niels O. S. [UNIFESP]
Universidade de São Paulo (USP)
Universidade Federal de São Paulo (UNIFESP)
Keywords: Lipopolysaccharide
Bradykinin
Bradykinin B(1) receptor
Acute lung injury
Issue Date: 25-May-2010
Publisher: Elsevier B.V.
Citation: European Journal of Pharmacology. Amsterdam: Elsevier B.V., v. 634, n. 1-3, p. 132-137, 2010.
Abstract: Lipopolysaccharides from gram-negative bacteria are amongst the most common causative agents of acute lung injury, which is characterized by an inflammatory response, with cellular infiltration and the release of mediators/cytokines. There is evidence that bradykinin plays a role in lung inflammation in asthma but in other types of lung inflammation its role is less clear. in the present study we evaluated the role of the bradykinin B(1) receptor in acute lung injury caused by lipopolysaccharide inhalation and the mechanisms behind bradykinin actions participating in the inflammatory response. We found that in C57BI/6 mice, the bradykinin B(1) receptor expression was up-regulated 24 h after lipopolysaccharide inhalation. At this time, the number of cells and protein concentration were significantly increased in the bronchoalveolar lavage fluid and the mice developed airway hyperreactivity to methacholine. in addition, there was an increased expression of tumor necrosis factor-alpha, interleukin-1 beta and interferon-gamma and chemokines (monocytes chemotactic protein-1 and KC) in the bronchoalveolar lavage fluid and in the lung tissue. We then treated the mice with a bradykinin B, receptor antagonist, R-954 (Ac-Orn-[Oic(2), alpha-MePhe(5), D-beta Nal(7), Ile(8)]desArg(9)-bradykinin), 30 min after lipopolysaccharide administration. We observed that this treatment prevented the airway hyperreactivity as well as the increased cellular infiltration and protein content in the bronchoalveolar lavage fluid. Moreover, R-954 inhibited the expression of cytokines/chemokines. These results implicate bradykinin, acting through B(1) receptor, in the development of acute lung injury caused by lipopolysaccharide inhalation. (C) 2010 Elsevier B.V. All rights reserved.
URI: http://repositorio.unifesp.br/handle/11600/32550
ISSN: 0014-2999
Other Identifiers: http://dx.doi.org/10.1016/j.ejphar.2010.02.002
Appears in Collections:Em verificação - Geral

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.